Status:

COMPLETED

Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis

Lead Sponsor:

Chang Gung Memorial Hospital

Conditions:

Pulmonary Tuberculosis

Genetic Variants of Host

Eligibility:

All Genders

20-90 years

Brief Summary

Infection with Mycobacterium tuberculosis remains at epidemic levels globally. Innate and adaptive immune responses evolve as protective mechanisms against mycobacterial infection in humans. Toll-like...

Detailed Description

Infection with Mycobacterium tuberculosis (TB) remains at epidemic levels globally. One third of the word's population is infected with this organism, making tuberculosis the most prevalent infectious...

Eligibility Criteria

Inclusion

  • a) findings on CXR that are compatible with presentations of Mycobacterium tuberculosis b) clinical symptoms, such as fever, body weight loss, night sweating, chest pain and chronic cough, that indicate active infection of pulmonary tuberculosis (TB) c) microbiological diagnosis by sputum smear and culture, bronchoalveolar lavage fluid culture, or DNA probe examination.
  • d) Resolution on CXR with anti-TB regimens e) Written informed consent form prior to participation into this study

Exclusion

  • a) concurrent active disease of other chronic illnesses, such as lung cancer, chronic bronchitis and bronchial asthma b) poor physical conditions that make any examination infeasible c) participation in another trial with use of an investigated drug within on month d) use of corticosteroid or immunosuppressant drugs

Key Trial Info

Start Date :

August 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2009

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00772408

Start Date

August 1 2006

End Date

November 1 2009

Last Update

February 28 2013

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung Hsien, Taiwan, Taiwan, 886

2

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung, Taiwan, Taiwan, 886

Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis | DecenTrialz